OLINVACIMAB
UNII VFH55IZ5VI

Substance Identification & Data

This profile provides standardized clinical and technical data for Olinvacimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VFH55IZ5VI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2095504-49-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VFH55IZ5VI

CAS Registry Number

2095504-49-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OLINVACIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C102877

National Cancer Institute reference terminology for clinical and research data.

INN ID

10829

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Olinvacimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OLINVACIMAB

Common Names & Synonyms

FULLY HUMAN MONOCLONAL ANTIBODY TARGETS VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2

IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2) (HUMAN MONOCLONAL TTAC-0001 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TTAC-0001 LIGHT CHAIN, DIMER

OLINVACIMAB [INN]

OLINVACIMAB [WHO-DD]

TANIBIRUMAB